GlassScriptPhysician profile
Eugene Koshkin
NPI 1487793428
$10,454.81
in general payments reported to CMS, 2019-2025
17 companies · $1,203 in 2025
The $1,203 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,559 · 2020: $689 · 2021: $1,036 · 2022: $1,450 · 2023: $2,514 · 2024: $2,005 · 2025: $1,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,598 · Travel and Lodging: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,597.77 |
| Travel and Lodging | $1,123.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,957.64 | 2019-2024 | Senza |
| Abbott Laboratories | $2,470.55 | 2019-2025 | Eterna, Proclaim |
| Medtronic, INC. | $1,781.09 | 2021-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Intellis Adaptivestim |
| Orthofix Medical, INC. | $1,319.32 | 2023 | Forza, Firebird, Sambascrew |
| Globus Medical, INC. | $293.74 | 2025 | Senza |
| Boston Scientific Corporation | $276.80 | 2021-2024 | |
| Allergan, INC. | $197.37 | 2019-2020 | |
| Relievant Medsystems, INC. | $196.75 | 2021-2023 | Intracept |
| Stratus Medical, LLC | $192.52 | 2022-2023 | Nimbus |
| Spr Therapeutics, INC | $191.12 | 2023-2024 | Sprint Pns System |
| Medtronic USA, INC. | $133.70 | 2019 | |
| Abbvie INC. | $124.21 | 2021 | |
| Mimedx Group, INC. | $122.29 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $104.68 | 2021 | |
| Nalu Medical, INC. | $32.74 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $31.56 | 2024 | Entyvio |
| Pacira Therapeutics, INC. | $28.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Koshkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.